Found: 8
Select item for more details and to access through your institution.
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 243, doi. 10.1007/s10549-023-06881-8
- By:
- Publication type:
- Article
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 3, p. 555, doi. 10.1007/s10549-021-06417-y
- By:
- Publication type:
- Article
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 1, p. 153, doi. 10.1007/s10549-021-06475-2
- By:
- Publication type:
- Article
A randomized trial of nurse‐administered behavioral interventions to manage anticipatory nausea and vomiting in chemotherapy.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1733, doi. 10.1002/cam4.2863
- By:
- Publication type:
- Article
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 7, p. 1853, doi. 10.1245/s10434-016-5662-9
- By:
- Publication type:
- Article
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 4, p. 1, doi. 10.1093/jncics/pkab054
- By:
- Publication type:
- Article